Further, Kondratskyi et al. demonstrated that, in prostate cancer cells, SOCE inhibitor (ML-9) stimulates autophagosome formation and inhibits autophagosome degradation independent of SOCE and STIM1 (Kondratskyi et al., 2014). Here, STIM1 is linked to prostate carcinoma.